Inflammatory diseases include a vast array of disorders and conditions that are characterized by inflammation. Examples include allergy, asthma, autoimmune diseases, coeliac disease ...

Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 Company reports topline ...

The Rhinology and Sinus Surgery Program provides comprehensive care for inflammatory, infectious, and neoplastic diseases of the sinus and nasal cavities. Our subspecialist physicians treat patients ...

Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...

A major cause of inflammatory bowel disease (IBD) has been discovered by UK scientists. They found a weak spot in our DNA that is present in 95% of people with the disease. It makes it much easier ...

The Center for Translational Research on Inflammatory Diseases was inaugurated at Michael E. DeBakey VA Medical Center in the Spring of 2013. CTRID is composed of MEDVAMC-based Baylor College of ...

It is classified as one of the two inflammatory bowel diseases along with Crohn’s disease. Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work ...

LYR-210 is a bioresorbable nasal implant designed to deliver six months of continuous anti-inflammatory medication (mometasone furoate) to the sinonasal passages for the treatment of CRS.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Here’s how you can bounce back. If you have Crohn’s disease or ulcerative colitis, you may be more likely to have some types of skin problems. Here’s what to watch for.

WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company ...

More information: Tom Thomas et al, A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease, Nature Immunology (2024). DOI: 10.1038/s41590-024-01994 ...